Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell & Gene Therapy and Cancer Immunotherapy Asia 2022

Cell & Gene Therapy and Cancer Immunotherapy Asia 2022

Date: Wednesday, 25 May 2022 - Thursday, 26 May 2022
Location: Tokyo, Japan

Conference Chairs

Yasufumi Kaneda

Yasufumi Kaneda
Professor and Vice-President/Provost, Osaka University

Norio Nakatsuji

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Keynote Speakers

Hiroshi Kawamoto

Hiroshi Kawamoto
Professor, Laboratory of Immunology, Institute for Frontier Life and Medical Sciences, Kyoto University

Osamu Nureki

Osamu Nureki
Professor, The University of Tokyo

Hiroshi Nagashima

Hiroshi Nagashima
Director and Professor, Meiji University International Institute for Bio-Resource Research


SelectBIO is pleased to welcome you to the Third Annual Cell & Gene Therapy and Cancer Immunotherapy Asia 2022 which will be held at the Nikko Narita, Japan on May 25-26, 2022.

This conference brings together academic and industry participants focusing on many aspects of this rapidly expanding and evolving field including stem cells for cellular therapy, ESCs and iPSCs and their deployment for cell & gene therapy, cancer immunotherapy including CAR-T therapy, and clinical application and technologies for gene therapy.

The conference addresses the whole ecosystem of Cell & Gene Therapy and Cancer Immunotherapy with a focus on technology platforms being developed to bring cell & gene therapy and regenerative medicine to the clinic.

In addition to presentations from academics, the program includes an emphasis on presentations from companies as well as posters to illustrate late-breaking research and an exhibit hall with companies seeking to engage with delegates from Europe, US, across Asia/Pacific and Japan.

SelectBIO is honored that Professor Norio Nakatsuji, Professor Emeritus, Kyoto University will be leading the conference as Conference Chairman.

Proof of Covid-19 Vaccination Required in Order to Participate On-Site at this Event.  Participants Not Vaccinated for Covid-19 Can Participate Virtually at this Event.

Agenda Topics

  • Biomarkers & Companion Diagnostics for Targeting Cancer Immunotherapy
  • Checkpoint and Non-Checkpoint Immunotherapies
  • Chimeric Antigen Receptor (CAR) T-Cells in Cancer Immunotherapy
  • Clinical Trials and Commercialization of Cell Therapies
  • Combination Cancer Immunotherapy
  • ESC and iPSC-derived Cells for Cellular Therapy and Clinical Deployment
  • Gene Therapy into the Clinic
    • Clinical Pipeline
    • Regulatory Landscape
    • Technology Platforms
  • Immunomodulatory Antibodies
  • Mesenchymal Stem Cells (MSCs): Their Potential for Cellular Therapy
  • Small Molecules in Cancer Immunotherapy
  • Stem Cells for Cellular Therapy
  • Targeting Signaling Pathways in Cancer as Therapeutic Intervention

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Confirmed Speakers to date

Hideki Mochizuki, Professor and Chairman, Osaka University Graduate School of Medicine
Takafumi Nakamura, Associate Professor, Division of Molecular Medicine, Tottori University
Sadao Ota, Associate Professor, University of Tokyo
Noriko Shimasaki, Research Assistant Professor, Goh Foundation Director of Advanced Cellular Therapy Laboratory, National University of Singapore
Haruka Yoshie, Application Specialist, CELLINK

Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Agenda is not currently available
Add to Calendar ▼2022-05-25 00:00:002022-05-26 00:00:00Europe/LondonCell and Gene Therapy and Cancer Immunotherapy Asia 2022Cell and Gene Therapy and Cancer Immunotherapy Asia 2022 in Tokyo, JapanTokyo,